| Literature DB >> 24871945 |
Lixin Wan1, Mingjia Tan2, Jie Yang3, Hiroyuki Inuzuka1, Xiangpeng Dai1, Tao Wu4, Jia Liu5, Shavali Shaik1, Guoan Chen6, Jing Deng7, Marcos Malumbres8, Anthony Letai7, Marc W Kirschner4, Yi Sun2, Wenyi Wei9.
Abstract
Anaphase-promoting complex Cdc20 (APC(Cdc20)) plays pivotal roles in governing mitotic progression. By suppressing APC(Cdc20), antimitotic agents activate the spindle-assembly checkpoint and induce apoptosis after prolonged treatment, whereas depleting endogenous Cdc20 suppresses tumorigenesis in part by triggering mitotic arrest and subsequent apoptosis. However, the molecular mechanism(s) underlying apoptosis induced by Cdc20 abrogation remains poorly understood. Here, we report the BH3-only proapoptotic protein Bim as an APC(Cdc20) target, such that depletion of Cdc20 sensitizes cells to apoptotic stimuli. Strikingly, Cdc20 and multiple APC-core components were identified in a small interfering RNA screen that, upon knockdown, sensitizes otherwise resistant cancer cells to chemoradiation in a Bim-dependent manner. Consistently, human adult T cell leukemia cells that acquire elevated APC(Cdc20) activity via expressing the Tax viral oncoprotein exhibit reduced Bim levels and resistance to anticancer agents. These results reveal an important role for APC(Cdc20) in governing apoptosis, strengthening the rationale for developing specific Cdc20 inhibitors as effective anticancer agents.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24871945 PMCID: PMC4081014 DOI: 10.1016/j.devcel.2014.04.022
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270